AbbVie, Voyager Launch Up-to-$1.1B+ Gene Therapy Collaboration to Treat Alzheimer's, Neurodegenerative Diseases

 AbbVie, Voyager Launch Up-to-$1.1B+ Gene Therapy Collaboration to Treat Alzheimer's, Neurodegenerative Diseases
  1. AbbVie, Voyager Launch Up-to-$1.1B+ Gene Therapy Collaboration to Treat Alzheimer's, Neurodegenerative Diseases  Genetic Engineering & Biotechnology News
  2. With $69M Deal, AbbVie Turns to Voyager for an Alzheimer's Gene Therapy  Xconomy
  3. AbbVie doubles down on tau with Voyager Alzheimer's deal  FierceBiotechFull coverage

Read More ...
AbbVie, Voyager Launch Up-to-$1.1B+ Gene Therapy Collaboration to Treat Alzheimer's, Neurodegenerative Diseases published February 20, 2018 at 09:43PM. Original Source Link : https://www.genengnews.com/gen-news-highlights/abbvie-voyager-launch-up-to-11b-gene-therapy-collaboration-to-treat-alzheimers-neurodegenerative-diseases/81255506
loading...

Related Posts :

0 Response to "AbbVie, Voyager Launch Up-to-$1.1B+ Gene Therapy Collaboration to Treat Alzheimer's, Neurodegenerative Diseases"

Posting Komentar